Jagsonpal Pharmaceuticals Ltd

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Company as a part of its investors engagement activities has scheduled a conference call with the Analysts / Investors on Thursday January 22 2026 to discuss its Q3 FY26 financial results. The Conference call details is attached as Annexure.